- Amorepacific’s fourth-quarter operating profit was 78.48 billion won, which missed the estimate of 81.18 billion won but showed an increase from 20.68 billion won year-over-year.
- The company reported a net loss of 54.52 billion won in the fourth quarter, contrasting with a net profit of 42.73 billion won in the previous year and missing the estimated profit of 52.74 billion won.
- Fourth-quarter sales reached 1.09 trillion won, marking an 18% increase year-over-year and surpassing the estimate of 1.05 trillion won.
- For the full year 2024, Amorepacific achieved an operating profit of 220.48 billion won, below the estimated figure of 225.51 billion won.
- The full-year net was 593.19 billion won, falling short of the estimated 690.68 billion won.
- Annual sales totalled 3.89 trillion won, exceeding the projected 3.85 trillion won.
- In terms of stocks, there are 27 buy recommendations, 1 hold, and 2 sell recommendations for Amorepacific.
A look at Amorepacific Corp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 2 | |
| Growth | 5 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Amorepacific Corp, a company specializing in skincare, makeup, and fragrance products, is poised for strong long-term growth. With a high growth score of 5, the company demonstrates promising potential for expanding its market presence and revenue streams. Additionally, boasting a resilience score of 4, Amorepacific is well-positioned to weather economic uncertainties and market fluctuations effectively, indicating stability in the face of challenges.
While Amorepacific scores moderately on value and momentum, with scores of 3 and 3 respectively, its dedication to growth and resilience stands out. The company’s commitment to innovation and adaptability in the beauty and personal care industry bodes well for its future performance and market position.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
